Database Member Home
RAS Member Home
Building and maintaining effective Key Opinion Leader (KOL) relationships can help drive successful development and commercialization of biopharmaceutical drugs and medical devices. In wake of an increasingly restricted and competitive environment, biopharmaceutical companies must optimize their KOL management structure and responsibility. The best organizational structures for KOL management must align with scientific as well as commercial perspectives.
This video provides inputs on the organizational responsibility for thought leader management, optimal structure for managing Key Opinion Leaders, transparency in engaging with KOLs and the role of Medical Affairs in Key Opinion Leader management.
This video will provide important benchmarks around the responsibility and optimal organizational structure for Thought Leader management.
In pharma, regulatory and access restrictions have reshaped key interactions with thought leaders... (ID POP-267)
Read More »
Key Opinion Leaders (KOLs) are recognized as one of the most effective avenues for building awareness in medical and scientific communities... (ID POP-253)
Pharmaceutical and life science companies rely heavily on key opinion leaders (KOLs) to improve their credibility in the marketplace... (ID PSM-235)
Pharmaceutical and medical device organizations seek strategic insights and guidance to successfully navigate the complexities of the changing healthcare landscape... (ID PSM-319)